This live webinar is scheduled in Eastern Time (ET). Convert to your time zone
It will also be available on demand through May 31, 2025, following the live webinar.
Description
Accurate laboratory results are crucial to effective patient care, yet errors can arise that are impactful, costly, and far too common. Preanalytical errors make up the majority of diagnostic testing, accounting for ~43–75% of all laboratory errors in published studies. Despite this, there are limited tools available to laboratorians to capture and prevent preanalytical error.
In this webinar, Dr. Christopher Farnsworth will introduce studies from his own hospital and other institutions in which novel tools for detecting preanalytical error have been implemented. Further, Dr. Farnsworth will assess how these tools have been applied collaboratively with nursing and others within the hospital to improve laboratory results and patient outcomes.
Target Audience
This activity is designed for lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, pathologists, and other laboratory professionals overseeing/conducting within this topic.
Learning Objectives
At the end of this session, participants will be able to:
- Explain how to seek out preanalytical error data in your facility
- Assess the impact of preanalytical error on specimen quality and diagnostic accuracy
- Implement a multi-disciplinary approach to improve specimen collection and handling through the preanalytical phase to improve patient outcomes
Faculty
Christopher W. Farnsworth, PhD, DABCC
Section Head of Clinical Chemistry
Associate Professor of Pathology and Immunology
Washington University
St. Louis, MO, USA
Disclosures and Statement of Independence
The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.
The following faculty reported financial relationships:
- Christopher Farnsworth, PhD, DABCC
- Honorarium/Expenses: Abbott, Werfen
- Consultant Fee: Abbott, Werfen, Cytovale
- Grant/Research Support: Abbott, Roche, Beckman, Siemens, Sebia, Qiagen, Cepheid, Werfen, Biomerieux
Content Validity
All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
Accreditation Statement
This activity will be submitted for approval of up to 1.0 ACCENT® continuing education credits.
Successful Completion Statement
Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].